Values as of: 2024-07-07
ETF | Large Value | NYSE Arca
Last Closing
USD 40.56Change
0.00 (0.00)%Market Cap
USD 2.65BVolume
0.46MAnalyst Target
N/AVerdict
Verdict
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Value Line(R) Dividend Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is a modified equal-dollar weighted index comprised of U.S. exchange-listed securities of companies that pay above-average dividends and have potential for capital appreciation.
Company Website : www.ftportfolios.com
Currency: USD
Country : USA
Inception Date: 19/08/2003
Primary Benchmark: Value Line Dividend TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.74%
Management Expense Ratio: 0.70 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| RBOT | Vicarious Surgical Inc. | 0.53 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SCHD | Schwab U.S. Dividend Equity ET.. | 0.07 % |
+0.33 (+0.39%) |
USD 61.23B |
| DGRO | iShares Core Dividend Growth E.. | 0.08 % |
+0.40 (+0.64%) |
USD 30.15B |
| FNDX | Schwab Fundamental U.S. Large .. | 0.25 % |
+0.63 (+0.89%) |
USD 17.02B |
| SCHV | Schwab U.S. Large-Cap Value ET.. | 0.04 % |
+0.55 (+0.69%) |
USD 11.79B |
| SPYD | SPDR® Portfolio S&P 500 High .. | 0.08 % |
+0.20 (+0.44%) |
USD 6.77B |
| VOOV | Vanguard S&P 500 Value Index F.. | 0.15 % |
+1.25 (+0.66%) |
USD 5.21B |
| FDVV | Fidelity® High Dividend ETF | 0.30 % |
+0.17 (+0.34%) |
USD 3.58B |
| SPHD | Invesco S&P 500® High Dividen.. | 0.30 % |
+0.13 (+0.26%) |
USD 3.52B |
| IWX | iShares Russell Top 200 Value .. | 0.20 % |
+0.66 (+0.82%) |
USD 3.20B |
| LRGF | iShares U.S. Equity Factor ETF | 0.20 % |
+0.55 (+0.94%) |
USD 2.16B |
N/A
| Market Performance vs. Industry/Classification (Large Value) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | 1.15% | 58% | F | 33% | F | ||
| Total Return | 1.15% | 6% | D- | 36% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 2.37% | 4% | F | 40% | F | ||
| Dividend Return | 2.38% | 48% | F | 35% | F | ||
| Total Return | 4.75% | 6% | D- | 35% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 19.05% | 17% | F | 60% | D- | ||
| Dividend Return | 10.63% | 37% | F | 41% | F | ||
| Total Return | 29.68% | 13% | F | 57% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 5.67% | 13% | F | 60% | D- | ||
| Dividend Return | 7.68% | 9% | A- | 58% | F | ||
| Total Return | 2.02% | 44% | F | 46% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 13.65% | 92% | A | 67% | D+ | ||
| Risk Adjusted Return | 56.29% | 25% | F | 77% | C+ | ||
| Market Capitalization | 2.65B | 77% | C+ | 83% | B | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
